Skip to content
value.today

Gamida Cell Ltd.

GMDAUnlisted company
$46 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-73 M
value.today research
Employees
—

Gamida Cell Ltd. in brief

Gamida Cell Ltd. is an unlisted company in the Biotechnology industry, based in Israel. In the year to Dec 2020 it had sales of $0 M and a net loss of $73 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Gamida Cell Ltd. timeline

1 events, 2018
  1. 2018
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Gamida Cell Ltd. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Gamida Cell Ltd.

Acquisitions and changes
No longer listed: ticker GMDA is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$112 M$224 M$336 M$448 M20202021202220232024

World rank over time

▼ down 8,166 places since 2020
2020-01-01: #17190#17,19020202021-01-01: #12081#12,08120212022-01-07: #20815#20,81520222022-12-25: #22177#22,17720222023-07-30: #19667#19,66720232024-01-05: #25356#25,3562024

Rank in Israel: #175 (Jan 2020) · #113 (Jan 2021) · #265 (Jan 2022) · #255 (Dec 2022) · #215 (Jul 2023) · #330 (Jan 2024)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-73 M

Dec-2020 ending year

How Gamida Cell Ltd. compares in Biotechnology

  • Revenue$0 M · higher than 0% of 647

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Gamida Cell Ltd.🇮🇱$46 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Gamida Cell Ltd.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Gamida Cell Ltd.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Gamida Cell Ltd.? Suggest a correction